WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Atrium Innovations Inc. (ATB) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2013, Pages: 36

Summary

Atrium Innovations Inc. (Atrium) is a global leader in science-based dietary supplements. The company deals with development, manufacture and marketing nutritional supplements for the health and nutrition industry. It markets more than 2,000 health and nutrition finished products generated principally from natural sources and include minerals, vitamins and specialized products such as enzymes and probiotics.

Atrium Innovations Inc. Key Recent Developments

Feb 27, 2013: Atrium Innovations Reports Revenue Of $110.5m In Q4 2012
Nov 07, 2012: Atrium Innovations Reports Revenue Of $107.6m In Q3 2012
Aug 09, 2012: Atrium Innovations Reports Revenue Of $109.5m In Q2 2012
May 14, 2012: Atrium Innovations Reports Revenue Of $110m In Q1 2012
Apr 27, 2012: FTC Files Notice Of Appeal Against Recent Ruling In Favour Of Garden Of Life

This comprehensive SWOT profile of Atrium Innovations Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Atrium Innovations Inc. - Key Facts
Atrium Innovations Inc. - Key Employees
Atrium Innovations Inc. - Major Products and Services
Atrium Innovations Inc. - History
Atrium Innovations Inc. - Company Statement
Atrium Innovations Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Atrium Innovations Inc. - Business Description
Atrium Innovations Inc. - Corporate Strategy
Atrium Innovations Inc. - SWOT Analysis
SWOT Analysis - Overview
Atrium Innovations Inc. - Strengths
Strength - Geographical Diversified
Strength - Well Recognized Portfolio of Brands
Strength - Growth through Acquisitions
Atrium Innovations Inc. - Weaknesses
Weakness - Business Concentration: North America
Atrium Innovations Inc. - Opportunities
Opportunity - Changing Demographics
Opportunity - Growing Market for Nutritional Supplements
Opportunity - New product Launch
Atrium Innovations Inc. - Threats
Threat - Intense competition
Threat - Uncertain R&D Outcomes
Threat - Government Regulations
Atrium Innovations Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Atrium Innovations Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Atrium Innovations Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Atrium Innovations Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Atrium Innovations Inc., Recent Developments
Feb 27, 2013: Atrium Innovations Reports Revenue Of $110.5m In Q4 2012
Nov 07, 2012: Atrium Innovations Reports Revenue Of $107.6m In Q3 2012
Aug 09, 2012: Atrium Innovations Reports Revenue Of $109.5m In Q2 2012
May 14, 2012: Atrium Innovations Reports Revenue Of $110m In Q1 2012
Apr 27, 2012: FTC Files Notice Of Appeal Against Recent Ruling In Favour Of Garden Of Life
Feb 29, 2012: Atrium Innovations Reports Revenue Of $104.8m In Q4 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Atrium Innovations Inc., Key Facts
Atrium Innovations Inc., Key Employees
Atrium Innovations Inc., Major Products and Services
Atrium Innovations Inc., History
Atrium Innovations Inc., Subsidiaries
Atrium Innovations Inc., Key Competitors
Atrium Innovations Inc., Ratios based on current share price
Atrium Innovations Inc., Annual Ratios
Atrium Innovations Inc., Interim Ratios
Atrium Innovations Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Atrium Innovations Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Atrium Innovations Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Atrium Innovations Inc., Performance Chart (2007 - 2011)
Atrium Innovations Inc., Ratio Charts
Atrium Innovations Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Atrium Innovations Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Bioriginal Food & Science Corp.
FMI Holdings Ltd.
A&A Pharmachem Inc.
Labopharm Inc.
Cipher Pharmaceuticals Inc.

Customers who bought this item also bought